Uterine Growths (cont.)Medical Author:
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MDMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. Medical Editor:
William C. Shiel Jr., MD, FACP, FACR
William C. Shiel Jr., MD, FACP, FACRDr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology. In this Article
Other medical treatment for uterine fibroidsIt is important to remember that fibroids only require treatment if they cause bleeding or pain. There are several medical treatments available for fibroids. Birth control pills (oral contraceptives) will provide many benefits for women with fibroids. They decrease the amount of uterine bleeding by about 50% and decrease cramping pain during menstruation. They also seem to decrease the risk of fibroids. Other medical treatments include the use of drugs that turn off the production of estrogen from the ovaries (GnRH analogs). These medications are given for three to six months. When successful, they can shrink the fibroids by as much as 50%. Mifepristone (RU-486) is an antiprogestin drug that can shrink fibroids to an extent comparable to treatment with the GnRH analogs. This drug, sometimes known as the "morning-after pill," is also used to terminate early pregnancy. Treatment with mifepristone also reduces the bleeding associated with fibroids, but this treatment can be associated with adverse side effects such as overgrowth (hyperplasia) of the endometrium (uterine lining). Danazol (Danocrine) is an androgenic steroid hormone that has been used to reduce bleeding in women with fibroids, since this drug causes menstruation to cease. However, danazol does not appear to shrink the size of fibroids. The administration of raloxifene (Evista) (a drug used to prevent and treat osteoporosis in postmenopausal women) has been shown to decrease the size of fibroids in postmenopausal women, but results with this therapy in premenopausal women have been conflicting. Low dose formulations of oral contraceptives are also sometimes given to treat the abnormal bleeding associated with fibroids. Reviewed by William C. Shiel Jr., MD, FACP, FACR on 4/2/2012 Patient CommentsViewers share their comments
Uterine Growths - Treatments
Question: What treatment did you receive for your uterine growths?
Uterine Growths - Symptoms
Question: Did you experience any symptoms with your uterine growths? Please describe.
Uterine Growths - Surgery
Question: Did you have surgery for uterine growths (fibroids)? Please describe your experience.
Uterine Growths - Polyps
Question: What symptoms, if any, did you experience with your uterine polyps?
Uterine Growths - Adenomyosis
Question: What were your symptoms with adenomyosis? How was it diagnosed, and what was the treatment?
|
Get the latest health and medical information delivered direct to your inbox FREE!


